openPR Logo
Press release

Global Anti Viral Drugs Market Set to Surge at 6.5% CAGR from 2021-2028, Fueled by Rising Demand for Targeted Therapies and Increasing Viral Diseases

05-20-2024 04:09 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Dataintelo

/ PR Agency: Dataintelo
Dataintelo

Dataintelo

Dataintelo's latest publication reveals that the Global Anti Viral Drugs Market is poised to grow at a ๐‚๐€๐†๐‘ of 6.5% during the forecast period covering 2021 to 2028. This significant growth is primarily driven by the rising prevalence of viral diseases, rapidly growing geriatric population and escalating demand for targeted therapies.

Anti-viral drugs are critical in the contemporary healthcare landscape, especially given the substantial uptick in viral diseases. These drugs combat infections by inhibiting the development of pathogens, demonstrating their essential role in disease management. The current surge in demand for these drugs can be attributed to the surge in the number of viral diseases globally.

Additionally, the geriatric population is considered more vulnerable to several viral infections due to a generally weaker immune system associated with aging. Consequently, they contribute substantially to the demand for anti-viral drugs. As the global geriatric population continues to grow, so does the demand for anti-viral drugs.

Targeted therapies are emerging as an innovative alternative to traditional treatment models for a variety of health conditions. Their potential for greater efficacy and fewer side effects has led to an increase in demand, subsequently driving the growth of the anti-viral drugs market. An expanding customer base seeking targeted therapies is an evident driving factor promoting the growth of the overall market.

According to Dataintelo, these dynamics collectively contribute to the robust ๐‚๐€๐†๐‘ of 6.5% projected for the Global Anti Viral Drugs Market over 2021-2028. This robust growth trajectory presents a lucrative opportunity for key players in the pharmaceutical industry, as they seek to meet the burgeoning demand for effective anti-viral drugs.

The report further provides a comprehensive analysis of market trends, opportunities, challenges, and the competitive landscape. It covers all dimensions of the market, providing stakeholders with critical insights that can help them strategize effectively for the forecasted period

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @ https://dataintelo.com/request-sample/240184

๐“๐ก๐ข๐ฌ ๐ข๐ฌ ๐จ๐ง๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฆ๐จ๐ฌ๐ญ ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ง๐ ๐œ๐จ๐ฏ๐ž๐ซ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ:

The anti viral drugs market has been segmented on the basis of๐“๐ฒ๐ฉ๐ž
โ— Nucleotide Polymerase Inhibitor
โ— Reverse Transcriptase Inhibitor
โ— Protease Inhibitor
โ— Integrase Inhibitor
โ— Fusion Inhibitor
โ— Entry Inhibitor

๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง
โ— HIV
โ— Hepatitis
โ— HSV
โ— Influenza
โ— Respiratory Syncytial Virus
โ— Cytomegalovirus
โ— Human Papillomavirus

๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ
โ— Hospital Pharmacies
โ— Retail Pharmacies
โ— Online Pharmacies

๐๐š๐ญ๐ข๐ž๐ง๐ญ ๐๐จ๐ฉ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง
โ— Pediatric
โ— Adult
โ— Geriatric

๐‘๐ž๐ ๐ข๐จ๐ง
โ— Asia Pacific
โ— North America
โ— Latin America
โ— Europe
โ— Middle East & Africa

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ
โ— F. Hoffmann-La Roche
โ— GlaxoSmithKline
โ— Bristol-Myers-Squibb
โ— AbbVie
โ— Johnson & Johnson
โ— Merck & Co
โ— Aurobindo Pharma
โ— Cipla
โ— Dr Reddy's
โ— F. Hoffmann-La Roche



The anti-viral drugs market is dynamically evolving when classified by the type of drug used, its application, distribution channel, and patient population. The market is divided based on the type of drugs including Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitor, Protease Inhibitor, Integrase Inhibitor, Fusion Inhibitor, and Entry Inhibitor. These drugs have distinct therapeutic applications and are utilized for the treatment of various diseases like HIV, Hepatitis, HSV, Influenza, Respiratory Syncytial Virus, Cytomegalovirus, and Human Papillomavirus. The distribution channels for these drugs include Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, depending on the convenience and necessity of consumers. In terms of patient population, the market caters to a wide range including Pediatric, Adult, and Geriatric.

On a global canvas, the anti-viral drugs market can be segmented into regions such as Asia-Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America is considered a significant market owing to advanced healthcare infrastructure and high awareness levels regarding the availability of these drugs. Europe follows closely thanks to its strong pharmaceutical industry. In the Asia-Pacific region, a rise in disposable income of consumers and increasing health awareness are major drivers for market growth. Latin America and the Middle East & Africa are emerging markets and are expected to offer plentiful ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐Ÿ๐จ๐ซmarket expansion. Key players in the global anti-viral drugs market include well-established pharmaceutical companies such as F. Hoffmann-La Roche, GlaxoSmithKline, Bristol-Myers-Squibb, AbbVie, Johnson & Johnson, Merck & Co, Aurobindo Pharma, Cipla, and Dr Reddy's. These players have a strong foothold in the market, delivering quality drugs for treatment, enhancing patient care worldwide

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @ https://dataintelo.com/request-sample/240184

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ:

1. Increasing prevalence of viral infections: Various viral diseases such as HIV, Hepatitis, Influenza, etc., are increasing across the globe, fuelling the demand for antiviral drugs.

2. Research and development activities: The need for effective antiviral drugs has led to increased research and development activities worldwide. These developments are expected to drive the market growth.

3. Advances in technology: The constant technological advancements in the field of drug discovery and development are likely to act as a significant driver for the antiviral drugs market.

4. Emerging diseases: Emerging viral diseases such as COVID-19 provide a substantial market opportunity for antiviral drugs.

5. Increased healthcare spending: This enables increased accessibility and affordability of these drugs for a larger population.

Market ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ:

1. Development of broad-spectrum antiviral drugs: There is a significant opportunity in the development of antiviral drugs capable of targeting multiple viruses.

2. Emerging markets: Developing countries represent a vast opportunity for the antiviral drugs market, owing to rapidly increasing disease prevalence and improving healthcare infrastructure.

3. Growth in Personalized Medicine: Customizing medical treatment to individual characteristics, needs, and preferences of a patient continues to form an essential factor in healthcare. It offers a considerable opportunity in the antiviral drug market.

4. Nonexistent cures: Many viral diseases still do not have a known cure or vaccine, offering a wide-open market opportunity.

5. Combination therapies: Using a combination of different antiviral drugs to enhance efficacy is another prominent opportunity area in this market.

6. Increase in awareness: Various awareness programs by the government and non-government organizations about viral diseases can generate significant ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐Ÿ๐จ๐ซstakeholders in the antiviral drugs market

๐˜๐จ๐ฎ ๐œ๐š๐ง ๐๐ข๐ซ๐ž๐œ๐ญ๐ฅ๐ฒ ๐›๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐ซ๐จ๐ฆ: https://dataintelo.com/checkout/240184

This report by Dataintelo should ideally be purchased by big corporations, small and medium enterprises, startups, and even individual investors with interest in market research. Industry analysts, strategists, business development executives, marketing managers, technology and innovation directors, consultants, product managers, academicians, researchers, and students can also greatly benefit from the insights provided in the report.

Dataintelo should be your go-to option for comprehensive and in-depth market analysis because of the following reasons:

1) Dataintelo offers a wealth of information in its reports, including current trends, growth drivers, industry challenges, and potential opportunities in various market sectors.

2) The reports are meticulously researched and compiled by industry experts and seasoned analysts who employ both primary and secondary research methodologies.

3) Dataintelo aims to deliver actionable insights that can help businesses make data-driven strategic decisions to drive profitability and growth.

4) The company offers a range of reports covering various industries, thereby enabling businesses of all types and sizes to find the information they need.

5) The company's customer service is top-notch with a highly responsive team prepared to assist customers to understand the report, thus making the decision-making process smoother.

6) Customization of reports is also possible, allowing clients to receive information tailored to their specific needs.

7) Lastly, Dataintelo report subscriptions come with free quarterly updates, ensuring customers always have the most up-to-date information

Contact Us :
Dataintelo
Name - Alex Mathews
Phone No.: +1 909 414 1393
Email - sales@dataintelo.com
Website - https://dataintelo.com
Address - 500 East E Street, Ontario, CA 91764, United States.

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐œ๐š๐ง ๐›๐ž ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐ž๐ ๐š๐ฌ ๐ฉ๐ž๐ซ ๐ฒ๐จ๐ฎ๐ซ ๐ง๐ž๐ž๐.

๐„๐ฆ๐š๐ข๐ฅ ๐ฎ๐ฌ ๐จ๐ง - ๐ฌ๐š๐ฅ๐ž๐ฌ@๐๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ.๐œ๐จ๐ฆ

๐€๐›๐จ๐ฎ๐ญ ๐ƒ๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ:

๐ƒ๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ boasts extensive experience in creating tailored Market research reports across diverse industry verticals. With in-depth Market analysis, creative business strategies for new entrants, and insights into the current Market scenario, our reports undergo intensive primary and secondary research, interviews, and consumer surveys.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Anti Viral Drugs Market Set to Surge at 6.5% CAGR from 2021-2028, Fueled by Rising Demand for Targeted Therapies and Increasing Viral Diseases here

News-ID: 3504205 • Views: โ€ฆ

More Releases from Dataintelo

Carbon Carbon Composite Brake Disc Market Projected to Grow at a Steady CAGR of XX%, Segmented by Type, Manufacturing Process, Application, and More, Reveals Dataintelo Report
Carbon Carbon Composite Brake Disc Market Projected to Grow at a Steady CAGR of โ€ฆ
Dataintelo has recently unveiled a comprehensive analysis on the Carbon Carbon Composite Brake Disc Market in its latest report. The research, which is segmented by Type (2D C/C composite, 2.5D C/C composite, 3D C/C composite), by Manufacturing Process (Blow Moulding, Injection Moulding) and by Application (Motorsport, Aerospace, Heavy Vehicles), among other factors, anticipates the market to grow at a significant CAGR of XX% during the forecast period. The report considersโ€ฆ
AR Optical Waveguide Module Market to Expand at a Significant CAGR, Revealed in Dataintelo's Latest Research Report Covering In-Depth Analysis of Leading Players and Key Sectors
AR Optical Waveguide Module Market to Expand at a Significant CAGR, Revealed in โ€ฆ
Dataintelo has recently published a comprehensive study on the AR Optical Waveguide Module Market, revealing a forecast annual growth rate (CAGR) of XX%. The report is detailed and breaks down its research by aspects such as Light Detection (Infrared, Ultraviolet, Visible Light), Waveguide Type (Planar Waveguide, Channel Waveguide), Material Type (Polymer, LiNbO3, Glass, Silicon), Application (Telecommunication, Healthcare, Industrial, Aerospace and Defense), and Component (Input/Output Coupler, Waveguide Core, Cladding). The report segmentsโ€ฆ
6-Axis Robots Market Expected to Witness Significant Growth, Focusing on Key Players ABB Group, Yaskawa Electric Corporation, and Fanuc Corporation
6-Axis Robots Market Expected to Witness Significant Growth, Focusing on Key Pla โ€ฆ
In a newly published report from Dataintelo, it is revealed that the 6-Axis Robots Market is projected to experience a substantial growth, marking a significant CAGR in the forecast period. The comprehensive study is segmented by type, including Articulated, Cylindrical, Spherical, and Cartesian robots, and by application, encompassing Material Handling, Welding, Painting, and Assembly amongst others. Additionally, it explores various end-use industries, such as Automotive, Electrical and Electronics, Metals andโ€ฆ
XX% Growth Projected for Mesotherapy Market, Reveals Dataintelo's Detailed Study on Product Types, Applications, End-users, and Key Players
XX% Growth Projected for Mesotherapy Market, Reveals Dataintelo's Detailed Study โ€ฆ
In an insightful investigation of the Mesotherapy Market, Dataintelo unveils a comprehensive analysis of the key growth markers, restraints, and business prospects that will shape the industry dynamics in the coming years. The report is segmented by Product Type (Plant Extracts, Hormones, Enzymes, Vitamins, Others), by Application (Non-Surgical Liposuction, Body Contouring, Hair Restoration, Others), by End-user (Hospitals, Speciality Clinics, Aesthetic Centers), and by Technique (Nappage, Point by Point, Mesoperfusion, Mesolift,โ€ฆ

All 5 Releases


More Releases for Inhibitor

Immune Checkpoint Inhibitor
Immune Checkpoint Inhibitors Market Insights 2019, Global and Chinese Scenario is a professional and indepth study on the current state of the global Immune Checkpoint Inhibitors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Immune Checkpoint Inhibitors manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides anโ€ฆ
Galectin Inhibitor Therapeutics - Pipeline Analysis 2019
Galectins belong to the family of animal lectins and perform function by interacting with cytoplasmic and nuclear proteins, cell-surface and extracellular matrix glycoproteins and glycolipids to modulate signalling pathways. Studies have shown the crucial roles of galectin in cancer as they contribute to tumour cell survival, tumour metastasis, angiogenesis and neoplastic transformation. Download the sample Report @ https://www.pharmaproff.com/request-sample/1209 Many studies have demonstrated role of galectins in the pathogenesis of various diseases includingโ€ฆ
Galectin Inhibitor Therapeutics - Pipeline Analysis 2019
Galectins belong to the family of animal lectins and perform function by interacting with cytoplasmic and nuclear proteins, cell-surface and extracellular matrix glycoproteins and glycolipids to modulate signalling pathways. Studies have shown the crucial roles of galectin in cancer as they contribute to tumour cell survival, tumour metastasis, angiogenesis and neoplastic transformation. Download the sample Report @ https://www.pharmaproff.com/request-sample/1209 Many studies have demonstrated role of galectins in the pathogenesis of various diseases includingโ€ฆ
Neuroendocrine Carcinoma Market: Both tyrosine kinase inhibitor and mTOR inhibit โ€ฆ
Recently, Future Market Insights has presented value analysis and insights on the various disease types, treatment types and end users associated with the neuroendocrine carcinoma market across key regions in the globe. It has also included an in-depth analysis on the various key players participating in the global neuroendocrine carcinoma market along with key developments taking place during the 2017-2027 timeline. Future Market Insights, in its recent publication titled โ€œNeuroendocrineโ€ฆ
Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor o โ€ฆ
"The Report Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Summary Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) pipeline Target constitutes close to 10 molecules. Out of which approximately 3 molecules are developed by companies and remaining by the universities/institutes. The latest reportโ€ฆ
Cytokine Inhibitor Market Research Report 2017
Reports And Markets Publish a New Market Research Report On โ€“"Cytokine Inhibitor Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-cytokine-inhibitor-market-research-report-2017-1541209 In this report, the global Cytokine Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions,โ€ฆ